The process of end-of-life decision-making for patients with disorders of consciousness should include caregivers in bedside assessments and integrate advanced diagnostic brain imaging techniques when available.
Biomedical Alliance in Europe Calls for Strong Health Funding in Next EC Multiannual Financial Framework
November 6, 2025
BioMed Alliance and 17 other civil society organisations call on policy makers to ensure that the next multiannual EU budget will be fit-for-purpose to address current and future health threats.
Latest Posts
-
-
Research HighlightsResearch
Neurology Update: Coma and Chronic Disorders of Consciousness
February 5, 2021An international study showed that younger age, shorter time since injury, higher level of responsiveness and EEG reactivity to eye opening are all factors that can predict 6-month improvement among severely brain-injured patients. -
Research HighlightsResearch
Neurology Update: Coma and Chronic Disorders of Consciousness
February 5, 2021Habituation of auditory startle reflex should be considered as a sign of the minimally conscious state, as unresponsive patients who demonstrate this behaviour show increased brain activity and better outcomes compared to patients with inextinguishable startle reflexes. -
Research HighlightsResearch
Neurology Update: Coma and Chronic Disorders of Consciousness
February 5, 2021A Dutch nationwide prospective cohort study has been launched to monitor the outcomes of patients included in the Early Intensive Rehabilitation program, with a follow-up period of two years. -
Research HighlightsResearch
Neurology Update: Coma and Chronic Disorders of Consciousness
February 5, 2021Neurology Update: Coma and Chronic Disorders of Consciousness -
News from EAN member societiesCOVID-19
EMA’s Webinar on ”COVID-19 vaccination – what you need to know as a health professional”
February 5, 2021EMA is organising a webinar on “COVID-19 vaccination – what you need to know as a health professional” to reply to concerns and questions that health professionals might have about COVID-19 vaccines. -
The COVID 19 pandemic has affected people with neurological disease and reduced the care provided, with possible adverse sequelae, including frailty.
-
A new study has shown that a short-term palliative care intervention was seen positively by the patients and families and reduced costs, but did not alter symptom burden.
-
InterviewsEAN NewsCOVID-19Top Articles
COVID-19 around the World: Clinician interviews on experience and impact of the virus (South Africa)
February 5, 2021COVID-19 around the World: Clinician interviews on experience and impact of the virus (South Africa) -
Breaking newsCOVID-19Research
A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: the NeuroCOVID‐19 task Force of the European Academy of Neurology
February 3, 2021A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: the NeuroCOVID‐19 task Force of the european Academy of neurology -
Breaking newsCOVID-19Research
The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning
February 3, 2021The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning -
Breaking newsCOVID-19Research
Stroke acute management and outcomes during the COVID-19 outbreak: A cohort study from the Madrid stroke network
February 3, 2021Stroke acute management and outcomes during the COVID-19 outbreak: A cohort study from the Madrid stroke network -
Breaking newsCOVID-19Research
Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series
February 3, 2021Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series -
Breaking newsCOVID-19Research
Stroke management during the COVID-19 outbreak: challenges and results of a hub-center in Lombardy, Italy
February 3, 2021Stroke management during the COVID-19 outbreak: challenges and results of a hub-center in Lombardy, Italy -
Breaking newsCOVID-19Research
Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
February 3, 2021Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?









